CDT Equity Inc.
Stock exchange listing-rule deficiency notice (8-K Item 3.01)
The company reported in a Form 8-K (Item 3.01) filed on 28 May 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.
More details →Annual report filed late (NT 10-K)
The company filed Form NT 10-K with the SEC on 01 Apr 2026, notifying investors that its annual report would be late. A late annual report can point to accounting or audit problems, though the reason is sometimes routine.
More details →Change of auditor (8-K Item 4.01)
The company reported a change of its independent auditor in a Form 8-K (Item 4.01) filed on 29 Jun 2026. Auditor changes are often routine (rotation, cost, mergers), but can follow disagreements over accounting.
More details →Quarterly report filed late (NT 10-Q)
The company filed Form NT 10-Q with the SEC on 15 May 2026, notifying investors that its quarterly report would be late. Late filings can point to accounting or business problems, though the reason is sometimes routine.
More details →Pledge-related SEC filings found
Found 1 SEC Form 4 filing(s) mentioning 'pledged' for this company's insiders. No exact percentage is available from this source (unlike India's BSE disclosures) — this flags that pledge-related activity exists and is worth reviewing directly on SEC EDGAR, not a computed magnitude.
More details →CDT Equity Inc. — Overview & Financial Snapshot
CDT Equity Inc. (NasdaqCM: CDT) is a Healthcare company, ranked #338 of 6,774 companies globally and #47 of 4,000 in United States on PositoAI, with a Positivity Score of 24,645. Its market capitalisation is ₹1.38 Cr ($146,299), P/E ratio is 0.0 and P/B ratio is 0.00. It currently has 1 active red flag (PosiRed) and 4 yellow flags (PosiYellow, 9/10 points) on record.
For financial statements, ratio trends and score history, Go Deep →